Dawn Health and Merck Launch Next-Generation Digital Ecosystem for Growth Disorders

Published: 2025-05-07 02:00:00 ET MRK

Published on 05/07/2025 at 02:00, updated on 05/07/2025 at 05:35

Dawn Health and Merck have launched the next-generation digital ecosystem for growth disorders, designed to support patients with Growth Hormone Deficiency (GHD), their caregivers, and healthcare professionals (HCPs). This marks a step forward in digital solutions for GHD, enhancing accessibility, usability, and clinical support. Over the past year, Dawn Health and Merck have worked closely to evolve the mobile app and HCP portal at the core of this ecosystem.

Built on the end-to-end Dawn Platform, the updated tools offer a more intuitive and engaging experience. The updated app combines playful, child-friendly elements with a structured layout that supports caregivers. The redesigned HCP portal enables efficient treatment tracking and delivers timely clinical insights.

Enhanced security and localization capabilities support global rollout.